US3123613A - Method for producing z-pyridineal- - Google Patents
Method for producing z-pyridineal- Download PDFInfo
- Publication number
- US3123613A US3123613A US3123613DA US3123613A US 3123613 A US3123613 A US 3123613A US 3123613D A US3123613D A US 3123613DA US 3123613 A US3123613 A US 3123613A
- Authority
- US
- United States
- Prior art keywords
- pyridinealdoxime
- product
- methylsulfate
- water
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 239000003960 organic solvent Substances 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 16
- VRGKDCRTYBCJTA-WAYWQWQTSA-N (2Z)-2-(nitrosomethylidene)-1H-pyridine Chemical compound O=N\C=C1/NC=CC=C1 VRGKDCRTYBCJTA-WAYWQWQTSA-N 0.000 claims description 14
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 10
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 10
- HIGSLXSBYYMVKI-UHDJGPCESA-N [(E)-(1-methylpyridin-2-ylidene)methyl]-oxoazanium;chloride Chemical compound [Cl-].CN1C=CC=C\C1=C/[NH+]=O HIGSLXSBYYMVKI-UHDJGPCESA-N 0.000 claims description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 56
- 239000000047 product Substances 0.000 description 48
- MTFJSAGADRTKCI-YVMONPNESA-N O\N=C/C1=CC=CC=N1 Chemical compound O\N=C/C1=CC=CC=N1 MTFJSAGADRTKCI-YVMONPNESA-N 0.000 description 40
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 24
- 238000002844 melting Methods 0.000 description 24
- 239000000203 mixture Substances 0.000 description 20
- 239000002904 solvent Substances 0.000 description 18
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 14
- 238000001914 filtration Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N Isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- 229940053514 Anticholinesterase anti-dementia drugs Drugs 0.000 description 4
- 229940055075 Anticholinesterase parasympathomimetics Drugs 0.000 description 4
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N Dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- JBKPUQTUERUYQE-UHFFFAOYSA-O Pralidoxime Chemical class C[N+]1=CC=CC=C1\C=N\O JBKPUQTUERUYQE-UHFFFAOYSA-O 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 150000003841 chloride salts Chemical class 0.000 description 4
- 239000000544 cholinesterase inhibitor Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000000749 insecticidal Effects 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229940075522 Antidotes Drugs 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N Bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N Chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 229960002017 Echothiophate Drugs 0.000 description 2
- 229940050176 Methyl Chloride Drugs 0.000 description 2
- 206010028417 Myasthenia gravis Diseases 0.000 description 2
- 229960002362 Neostigmine Drugs 0.000 description 2
- ALWKGYPQUAPLQC-UHFFFAOYSA-N Neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M Silver chloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- MSFPLIAKTHOCQP-UHFFFAOYSA-M Silver iodide Chemical compound I[Ag] MSFPLIAKTHOCQP-UHFFFAOYSA-M 0.000 description 2
- ASCUXPQGEXGEMJ-GPLGTHOPSA-N [(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(4-methylanilino)oxan-2-yl]methoxy]oxan-2-yl]methyl acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](COC(=O)C)O[C@@H]1OC[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC=2C=CC(C)=CC=2)O1 ASCUXPQGEXGEMJ-GPLGTHOPSA-N 0.000 description 2
- QNBVYCDYFJUNLO-UHDJGPCESA-N [(E)-(1-methylpyridin-2-ylidene)methyl]-oxoazanium;iodide Chemical compound [I-].CN1C=CC=C\C1=C/[NH+]=O QNBVYCDYFJUNLO-UHDJGPCESA-N 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 230000003042 antagnostic Effects 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000002605 anti-dotal Effects 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002575 chemical warfare agent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 230000001809 detectable Effects 0.000 description 2
- 125000000532 dioxanyl group Chemical group 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- BJOLKYGKSZKIGU-UHFFFAOYSA-N ecothiopate Chemical compound CCOP(=O)(OCC)SCC[N+](C)(C)C BJOLKYGKSZKIGU-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- SEISMQVOJUJKGE-UHFFFAOYSA-M ethyl 1,6-dimethyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-1-ium-3-carboxylate;methyl sulfate Chemical compound COS([O-])(=O)=O.C1CCC(C)N2C(=O)C(C(=O)OCC)=C[N+](C)=C21 SEISMQVOJUJKGE-UHFFFAOYSA-M 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000009114 investigational therapy Methods 0.000 description 2
- 150000005451 methyl sulfates Chemical class 0.000 description 2
- 230000000607 poisoning Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000005956 quaternization reaction Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229940045105 silver iodide Drugs 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
Definitions
- the compound Z-pyridinealdoxime methochloride occurs as a white crystalline powder which is soluble in water to the extent of one gram in less than one cc.
- the chemical structure is as follows:
- the molecular weight is 173.
- the compound is currently of interest and under investigation as an antagonist to anticholinesterases and has been found to be of interest in the treatment of insecticide posioning, opthalmology, myasthenia gravis and, potentially, for the management of toxicity due to chemical warfare agents.
- 2-pyridinealdoxime methiodidc is converted to the chloride by contacting a solution of the iodide with solid silver chloride, filtering off the silver iodide formed and evaporating the aqueous solution to dryness at relatively low temperatures. This process requires an expensive re agent and tends to leave traces of silver in the product, which are difficult to remove.
- 2-pyridinealdoxime methiodide may be converted to the chloride by means of an anion exchange resin.
- This method is cumbersome and is also relatively expensive because of the fact that regeneration of the iodide saturated resin is dificult, and, like the method 1 above, it requires the evaporation of large volumes of water at low temperatures.
- This invention provides a method of convertingthe intermediate product Z-pyridinealdoxime metho-methylsulfate to the corresponding methochloride by a simple one-step operation which gives a high yield of pure product.
- the method of this invention utilizes the intermediate product Z-pyridinealdoxime metho-rnethylsulfate which is readily obtained from dimethyl sulfate and Z-pyrid'mealdoxime. This is converted into the Z-pyridinealcloxime methochloride by contacting it with water, hydrogen chloride and a water-miscible organic solvent.
- the salts of 2-formyl-l-methyl pyridinium oxime are known to be specific antidotes for anticholinesterases and are used for treatment of poisoning due to accidental contact with insecticides, such as neostigmine or echothiophate.
- insecticides such as neostigmine or echothiophate.
- the chloride appears to be clearly superior, because of solubility, stability, activity per unit weight and physiologic compatibility.
- Chloride Mel'hyl- Chloride Methylsulfate sulfate O. 16 0 0. l4 0. 20 0. 09 0. 53 1. 2 O. 89 3. 48 16. 0 8. 5 48. 5 Water 43. 3 65. 5 S7. 8 Isopropsnol, 10 v olum e s/ water, 1 volume 1.0 5. 4 1. 8 17.0
- Z-pyiidinealdoxime nietho-methylsulfate is dissolved in concentrated hydrochloric acid and a watermiscible organic solvent is added, ZTpyridinealdOXime methochloride will precipitate in a high degree of purity and good yield. Minute traces of sulfate are detectable in the product, but are without physiologic significance.
- the preferred solvent is isopropanol. Isobutanol, acetone,
- the process has been carried out successfully using from 1 to mols of hydrogen chloride per mol of methylsulfate salt, water in the amount of from 0.35 to 1.6 cc. per gram of starting material, and an organic solvent in the amount of from six to fifteen times the total volume of Water in the reaction mixture. Within this range the solvent ratio does not greatly affect the yield or purity of the product. Less than six volumes of solvent tends to reduce the yield. Proportions of about two mols of hydrogen chloride per mol of methylsulfate, 0.66 cc. of water per gram of methylsulfate and volumes of isopropanol per volume of Water give very satisfactory results.
- the preparation of the intermediate product, 2-pyridinealdoxime metho-methylsulfate is as follows. One kilogram of Z-pyridinealdoxime is dissolved in six liters of acetone and filtered until clear. Two kilograms (2 equivalents) of freshly distilled dimethyl sulfate are added and the solution mixed. In about 30 minutes crystals start to appear, after which a cooling bath is used to keep the temperature at about 30 to 35 C. until the reaction is nearly complete (about 2 hours). The mixture is allowed to stand at room temperature overnight, the crystals filtered off and washed on a filter with acetone. The product is obtained as colorless needles which melt at 111 to 112.5 C. The methylsulfate is not stable indefinitely. For preparation of pure chloride salt it is desirable to use methylsulfate which gives no titratable acidity with sodium hydroxide using bromphenolblue as indicator.
- EXAMPLE 2 Ten grams of Z-pyridinealdoxime methomethylsulfate is dissolved in 6 cc. of concentrated hydrochloric acid, and 60 cc. of acetone is added with stirring. At first two liquid layers appear, then a. slightly gummy precipitate, and finally a coarse granular precipitate is obtained. After two hours standing at room temperature, the crystals are separated by filtration and washed with acetone. The product had a melting point of 217- C. and the yield was 74.7%.
- EXAMPLE 4 The same method is used as described in Example 1, except that absolute ethanol is used in place of isopropanol. The product had a melting point of 2267 C. and the yield was 69.7%.
- EXAMPLE 5 The same method is used as described in Example 1, except that isobutanol is used in place of isopropanol. The crystals obtained are somewhat gummy at first, but soon become granular on mixing. The product had a melting point of 224-5 C. and the yield was 84.3%.
- EXAMPLE 7 Ten grams of Z-pyridinealdoxime methomethylsulfate is dissolved in 6 cc. of concentrated hydrochloric acid, and 60' cc. of dioxane is added. Two liquid layers appear at first, but stirring brings out a crop of crystals, which is filtered ofi after about 3 hours at room temperature, and washed with acetone. The product had a melting point of 2189 C. and the yield was 28.8%.
- EXAMPLE 8 Isopropanol, 60 cc., is mixed with 6 cc. of concentrated hydrochloric acid. Solid 2-pyridinealdoxime methomethylsulfate, 10 grams, is added and the mixture stirred for two hours at room temperature. The crystals are filtered off and washed with acetone. The product had a melting point of 2256 C. and the yield was 86.0%.
- EXAMPLE 9 The same method is used as described in Example 8, except that acetone is used in place of isopropanol. A slight gumminess is observed on first adding the methylsulfate, but the precipitate quickly becomes granular.
- the product had a melting point of 2256 C. and the yield was 74.6%
- EXAMPLE 10 Ten grams of 2-pyridinealdoxime methomethylsulfate is dissolved in 3.5 cc. of concentrated hydrochloric acid and 1.5 cc. of water. Fifty cc. of isopropanol is added. Crystals appear which are filtered off after two hours and washed with acetone. The product had a melting point of 2278 C. and the yield was 64.3%.
- EXAMPLE 11 Ten grams of Z-pyridinealdoxime metho-methylsulfate is dissolved in 8 cc. of concentrated hydrochloric acid and cc. of isopropanol is added. Crystals appear quickly, and are filtered oif after two hours at room temperature and washed with acetone. The product had a melting point of 229-30 C. and the yield was 84.2%.
- EXAMPLE 12 Ten grams of Z-pyridinealdoxime metho-methylsulfate is dissolved in 16 cc. of concentrated hydrochloric acid, and cc. of isopropanol is added. Crystals appear quickly, and are filtered off after two hour-s at room temperature and washed With acetone. The product had a melting point of 22930 C. and the yield was 81.7%.
- EXAMPLE 13 The same method is used as described in Example 11, except that the mixture is chilled in an ice bath before filtering off the product.
- the product had a melting point of 2267 C. and the yield was 91.4%.
- Method for the preparation of Z-pyridinealdoxime methochloride which comprises reacting Z-pyridinealdoxime metho-methylsulfate with hydrogen chloride in the presence of water and a water-miscible organic solvent.
- Method for the preparation of Z-pyridinealdoxime methochloride which comprises mixing Z-pyridinealdoxime metho-methylsulfate with hydrochloric acid and adding a water-miscible organic solvent to the mixture.
- Method for the preparation of Z-pyridinealdoxime methochloride which comprises forming a mixture of hydrochloric acid and a water-miscible organic solvent, and adding to said mixture Z-pyridinealdoxime metho-methylsulfate.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Description
United States Patent ()fiice 3,123,613 Patented Mar. 3, 1964 3,123,613 METHOD FOR PRSDUCING l-PYRIDINEAL- DOXIME METHOCHLGRIDE Lillian P. Bloch, Jamaica, N.Y., assignor to Campbell Pharmaceuticals, Enc., New York, N.Y., a corporation of Delaware No Drawing. Filed May 5, 1961, Ser. No. 107,894 8 Claims. (Cl. 26ll-296) The present invention relates to a novel method for the manufacture of Z-pyridinealdoxime methochloride. The novel method is practical, economical and uses readily available raw materials which yield a product of high purity suitable for drug use and especially for the preparation of solutions for intravenous injections.
The compound Z-pyridinealdoxime methochloride occurs as a white crystalline powder which is soluble in water to the extent of one gram in less than one cc. The chemical structure is as follows:
The molecular weight is 173. The compound is currently of interest and under investigation as an antagonist to anticholinesterases and has been found to be of interest in the treatment of insecticide posioning, opthalmology, myasthenia gravis and, potentially, for the management of toxicity due to chemical warfare agents.
Prior methods for the preparation of Z-pyridinealdoxirne methochloride are as follows:
(1) 2-pyridinealdoxime methiodidc is converted to the chloride by contacting a solution of the iodide with solid silver chloride, filtering off the silver iodide formed and evaporating the aqueous solution to dryness at relatively low temperatures. This process requires an expensive re agent and tends to leave traces of silver in the product, which are difficult to remove.
(2) 2-pyridinealdoxime methiodide may be converted to the chloride by means of an anion exchange resin. This method is cumbersome and is also relatively expensive because of the fact that regeneration of the iodide saturated resin is dificult, and, like the method 1 above, it requires the evaporation of large volumes of water at low temperatures. There are similar objections to conversion of other salts, such as the methylsulfate, to the chloride by this means.
(3) Direct quaternization of Z-pyridinealdoxime with methyl chloride can be carried out if a pressure reactor is used, but poor yields are obtained and the product requires several recrystaliizations toreach an acceptable purity.
This invention provides a method of convertingthe intermediate product Z-pyridinealdoxime metho-methylsulfate to the corresponding methochloride by a simple one-step operation which gives a high yield of pure product. i
The method of this invention utilizes the intermediate product Z-pyridinealdoxime metho-rnethylsulfate which is readily obtained from dimethyl sulfate and Z-pyrid'mealdoxime. This is converted into the Z-pyridinealcloxime methochloride by contacting it with water, hydrogen chloride and a water-miscible organic solvent.
The salts of 2-formyl-l-methyl pyridinium oxime are known to be specific antidotes for anticholinesterases and are used for treatment of poisoning due to accidental contact with insecticides, such as neostigmine or echothiophate. Of the various salts that have been tested, the chloride appears to be clearly superior, because of solubility, stability, activity per unit weight and physiologic compatibility. Although the solubility in water of the chloride and methyl sulfate salts of Z-formyl-l-methylpyridinium oxime is about the same, it was found that 2- pyridineaidoxime metho-methylsulfate is considerably more soluble than Z-pyridinealdoxime methochloride in organic solvents, and strikingly more so in a mixture of water and an organic solvent. As is shown from Table I it is clear, that at room temperature, the methylsulfate is almost ten times as soluble as the chloride in a 10 to 1 mixture of isopropanol and water.
TABLE I Solubility of Z-Pyridinealdoxime Methochloride and 2- Pyridinealdoxime Metho-Methylsulfale in Various Solvents Solubility in gm. per 106 cc. of solution Solvent 0 C. 25 C.
Chloride Mel'hyl- Chloride Methylsulfate sulfate O. 16 0 0. l4 0. 20 0. 09 0. 53 1. 2 O. 89 3. 48 16. 0 8. 5 48. 5 Water 43. 3 65. 5 S7. 8 Isopropsnol, 10 v olum e s/ water, 1 volume 1.0 5. 4 1. 8 17.0
Thus, if Z-pyiidinealdoxime nietho-methylsulfate is dissolved in concentrated hydrochloric acid and a watermiscible organic solvent is added, ZTpyridinealdOXime methochloride will precipitate in a high degree of purity and good yield. Minute traces of sulfate are detectable in the product, but are without physiologic significance. The preferred solvent is isopropanol. Isobutanol, acetone,
- ethanol, methanol, propylene glycol and dioxane have all and the solvent added with stirring. This causes precipitation of the chloride salt which is filtered olf.
(b) The concentrated hydrochloric acid and the solvent are premixed, the Z-pyridinealdoxime metho-methylsulfate is added as a solid and the mixture agitated for about two hours at room temperature, after which the precipi- .3, tate is filtered 011?. In this case an actual solution is never seen, but at equilibrium a product is obtained which contains less than 1% of unconverted methylsulfate.
The process has been carried out successfully using from 1 to mols of hydrogen chloride per mol of methylsulfate salt, water in the amount of from 0.35 to 1.6 cc. per gram of starting material, and an organic solvent in the amount of from six to fifteen times the total volume of Water in the reaction mixture. Within this range the solvent ratio does not greatly affect the yield or purity of the product. Less than six volumes of solvent tends to reduce the yield. Proportions of about two mols of hydrogen chloride per mol of methylsulfate, 0.66 cc. of water per gram of methylsulfate and volumes of isopropanol per volume of Water give very satisfactory results.
The preparation of the intermediate product, 2-pyridinealdoxime metho-methylsulfate, is as follows. One kilogram of Z-pyridinealdoxime is dissolved in six liters of acetone and filtered until clear. Two kilograms (2 equivalents) of freshly distilled dimethyl sulfate are added and the solution mixed. In about 30 minutes crystals start to appear, after which a cooling bath is used to keep the temperature at about 30 to 35 C. until the reaction is nearly complete (about 2 hours). The mixture is allowed to stand at room temperature overnight, the crystals filtered off and washed on a filter with acetone. The product is obtained as colorless needles which melt at 111 to 112.5 C. The methylsulfate is not stable indefinitely. For preparation of pure chloride salt it is desirable to use methylsulfate which gives no titratable acidity with sodium hydroxide using bromphenolblue as indicator.
The following examples are illustrative of the process of the present invention for producing 2-pyridinealdoxime methochloride and are not to be construed as limiting:
EXAMPLE 1 Ten grams of Z-pyridinealdoxime methomethylsulfate is dissolved in 6 cc. of concentrated hydrochloric acid, and 60 cc. of isopropanol is added with stirring. Crystals appear almost instantly. After two hours standing at room temperature, the crystals are separated by filtration and washed with acetone. The product had a melting point of 227-8 C. and the yield was 85%.
EXAMPLE 2 Ten grams of Z-pyridinealdoxime methomethylsulfate is dissolved in 6 cc. of concentrated hydrochloric acid, and 60 cc. of acetone is added with stirring. At first two liquid layers appear, then a. slightly gummy precipitate, and finally a coarse granular precipitate is obtained. After two hours standing at room temperature, the crystals are separated by filtration and washed with acetone. The product had a melting point of 217- C. and the yield was 74.7%.
EXAMPLE 3 Ten grams of 2-pyridinealdoxime methomethylsulfate is dissolved in 3.5 cc. of concentrated hydrochloric acid, and 35 cc. of methanol is added. Crystals appear slowly; the mixture is chilled for two hours in an ice bath, the crystals separated by filtration and washed with acetone. The product had a melting point of 2256 C. and the yield was 29.6%.
EXAMPLE 4 The same method is used as described in Example 1, except that absolute ethanol is used in place of isopropanol. The product had a melting point of 2267 C. and the yield was 69.7%.
EXAMPLE 5 The same method is used as described in Example 1, except that isobutanol is used in place of isopropanol. The crystals obtained are somewhat gummy at first, but soon become granular on mixing. The product had a melting point of 224-5 C. and the yield was 84.3%.
EXAMPLE 7 Ten grams of Z-pyridinealdoxime methomethylsulfate is dissolved in 6 cc. of concentrated hydrochloric acid, and 60' cc. of dioxane is added. Two liquid layers appear at first, but stirring brings out a crop of crystals, which is filtered ofi after about 3 hours at room temperature, and washed with acetone. The product had a melting point of 2189 C. and the yield was 28.8%.
EXAMPLE 8 Isopropanol, 60 cc., is mixed with 6 cc. of concentrated hydrochloric acid. Solid 2-pyridinealdoxime methomethylsulfate, 10 grams, is added and the mixture stirred for two hours at room temperature. The crystals are filtered off and washed with acetone. The product had a melting point of 2256 C. and the yield was 86.0%.
EXAMPLE 9 The same method is used as described in Example 8, except that acetone is used in place of isopropanol. A slight gumminess is observed on first adding the methylsulfate, but the precipitate quickly becomes granular.
. The product had a melting point of 2256 C. and the yield was 74.6%
EXAMPLE 10 Ten grams of 2-pyridinealdoxime methomethylsulfate is dissolved in 3.5 cc. of concentrated hydrochloric acid and 1.5 cc. of water. Fifty cc. of isopropanol is added. Crystals appear which are filtered off after two hours and washed with acetone. The product had a melting point of 2278 C. and the yield was 64.3%.
EXAMPLE 11 Ten grams of Z-pyridinealdoxime metho-methylsulfate is dissolved in 8 cc. of concentrated hydrochloric acid and cc. of isopropanol is added. Crystals appear quickly, and are filtered oif after two hours at room temperature and washed with acetone. The product had a melting point of 229-30 C. and the yield was 84.2%.
EXAMPLE 12 Ten grams of Z-pyridinealdoxime metho-methylsulfate is dissolved in 16 cc. of concentrated hydrochloric acid, and cc. of isopropanol is added. Crystals appear quickly, and are filtered off after two hour-s at room temperature and washed With acetone. The product had a melting point of 22930 C. and the yield was 81.7%.
EXAMPLE 13 The same method is used as described in Example 11, except that the mixture is chilled in an ice bath before filtering off the product. The product had a melting point of 2267 C. and the yield was 91.4%.
What is claimed is:
1. Method for the preparation of Z-pyridinealdoxime methochloride which comprises reacting Z-pyridinealdoxime metho-methylsulfate with hydrogen chloride in the presence of water and a water-miscible organic solvent.
2. Method for the preparation of Z-pyridinealdoxime methochloride which comprises mixing Z-pyridinealdoxime metho-methylsulfate with hydrochloric acid and adding a water-miscible organic solvent to the mixture.
3. Method for the preparation of Z-pyridinealdoxime methochloride which comprises forming a mixture of hydrochloric acid and a water-miscible organic solvent, and adding to said mixture Z-pyridinealdoxime metho-methylsulfate.
4. The method of claim 1 wherein the water-miscible solvent is a lower alkanol.
5. The method of claim 1 wherein said organic solvent is isopropanol.
6. The method of claim 1 wherein said organic solvent is acetone.
7. The method of claim 1 wherein said organic solvent is propylene glycol.
8. The method of claim 1 wherein said organic solvent is dioxane.
6 References Cited in the file of this patent UNITED STATES PATENTS 2,547,782 Rhodehamel Apr. 3, 1951 5 2,816,113 Wilson et al Dec. 10, 1957 2,859,217 Soper 1 Nov. 4, 1958 2,922,786 Sam Jan. 26, 1960 OTHER REFERENCES MacArdle: Use of Solvents in Syn. Org. Chem. (Van Nostrand), pp. 3, 40-50 (1925
Claims (1)
1. METHOD FOR THE PREPARATION OF 2-PYRIDINEALDOXIME METHOCHLORIDE WHICH COMPRISES REACTING 2-PYRIDINEALDOXIME METHO-METHYLSULFATE WITH HYDROGEN CHLORIDE IN THE PRESENCE OF WATER AND A WATER-MISCIBLE ORGANIC SOLVENT.
Publications (1)
Publication Number | Publication Date |
---|---|
US3123613A true US3123613A (en) | 1964-03-03 |
Family
ID=3453145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US3123613D Expired - Lifetime US3123613A (en) | Method for producing z-pyridineal- |
Country Status (1)
Country | Link |
---|---|
US (1) | US3123613A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3169907A (en) * | 1960-07-28 | 1965-02-16 | Hommel S A | Method of relieving migraine with 5-allyl-5-(beta-hydroxy-propyl)-barbituric acid |
US3285927A (en) * | 1965-03-02 | 1966-11-15 | Robert I Ellin | Preparation of methyl pyridinium-2-aldoxime chloride |
US3468896A (en) * | 1965-07-16 | 1969-09-23 | American Home Prod | Method of preparing 2-pyridinealdoxime methochloride |
CN116987025A (en) * | 2023-09-25 | 2023-11-03 | 成都瑞尔医药科技有限公司 | Crystal form of pralidoxime chloride and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2547782A (en) * | 1948-10-26 | 1951-04-03 | Lilly Co Eli | 2-chloroprocaine salt of penicillin |
US2816113A (en) * | 1956-07-10 | 1957-12-10 | Irwin B Wilson | Alkyl pyridinium salt, 2-carboxaldehyde oximes and process of preparation |
US2859217A (en) * | 1956-09-28 | 1958-11-04 | Lilly Co Eli | Acetylcholine esterase inhibitors |
US2922786A (en) * | 1956-12-12 | 1960-01-26 | Bristol Myers Co | Therapeutic compounds |
-
0
- US US3123613D patent/US3123613A/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2547782A (en) * | 1948-10-26 | 1951-04-03 | Lilly Co Eli | 2-chloroprocaine salt of penicillin |
US2816113A (en) * | 1956-07-10 | 1957-12-10 | Irwin B Wilson | Alkyl pyridinium salt, 2-carboxaldehyde oximes and process of preparation |
US2859217A (en) * | 1956-09-28 | 1958-11-04 | Lilly Co Eli | Acetylcholine esterase inhibitors |
US2922786A (en) * | 1956-12-12 | 1960-01-26 | Bristol Myers Co | Therapeutic compounds |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3169907A (en) * | 1960-07-28 | 1965-02-16 | Hommel S A | Method of relieving migraine with 5-allyl-5-(beta-hydroxy-propyl)-barbituric acid |
US3285927A (en) * | 1965-03-02 | 1966-11-15 | Robert I Ellin | Preparation of methyl pyridinium-2-aldoxime chloride |
US3468896A (en) * | 1965-07-16 | 1969-09-23 | American Home Prod | Method of preparing 2-pyridinealdoxime methochloride |
CN116987025A (en) * | 2023-09-25 | 2023-11-03 | 成都瑞尔医药科技有限公司 | Crystal form of pralidoxime chloride and preparation method thereof |
CN116987025B (en) * | 2023-09-25 | 2024-01-26 | 成都瑞尔医药科技有限公司 | Crystal form of pralidoxime chloride and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4988731A (en) | Sodium hydrogen divalproate oligomer | |
US3254093A (en) | Process for preparing pyrazoles | |
DE2901170C2 (en) | ||
US2969364A (en) | Derivatives of 5-amino uracil | |
US3123613A (en) | Method for producing z-pyridineal- | |
US2960441A (en) | Therapeutic compositions of salts of 3, 3-pentamethylene-4-hydroxybutyric acid | |
DE69318188T3 (en) | VINYL ESTER SYNTHESIS | |
US3148940A (en) | Preparation of a hydroxylamine coordination compound | |
US3000899A (en) | 1-r-2-amino-indoles | |
US2649456A (en) | Alpha, alpha-diphenyl-gamma-(nu-methyl-2-piperidyl)-butyramides and acid addition and quaternary ammonium derivatives thereof | |
US2897205A (en) | 1-etherified oxyalkyl imidazole-4,5-dicarboxamides, intermediates and process | |
US2628237A (en) | Alkali metal salts of isonicotinylhydrazinomethanesulfinic acid | |
US2706738A (en) | Method of preparing pyrophosphortetraamides of secondary aliphatic and secondary heterocyclic amines in the presence of an inorganic base | |
US3221050A (en) | 2-cycloalkylcarbonylamido-5-halobenzophenones | |
US2655507A (en) | Pyrazole compounds | |
US2764594A (en) | Pentachlorophenol salt of 3-amino-1, 2, 4-triazole | |
US3117127A (en) | 3-and 4-acetamidopiperidinium halides | |
US3342830A (en) | Method for producing 2, 2'-bipyridylium salts | |
US2741609A (en) | N-chjchjchj | |
US2957876A (en) | N-aminopiperidinium salt | |
US2819268A (en) | New chemical compound and its method of preparation | |
US2899462A (en) | Production of z-carboxy-z-cakboxymeth- | |
JP3095191B2 (en) | Crystallization method | |
US2580832A (en) | Preparation of nitrilotrispropion-amide | |
US3027408A (en) | 2-(benzylcarbamyl)-ethyl substituted oxalic acid hydrazide |